Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults
Clinical trial NCT01462253 · COMPLETED
Trial details
- NCT number
- NCT01462253
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2017-03-11
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.